Olema Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Olema Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(5.44%),Deep Track Biotechnology Master Fund, Ltd.(5.44%), etc.
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zojwalla Naseem
Olema Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Olema Pharmaceuticals | 10-K: Annual report
Olema Pharmaceuticals | 8-K: Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director RAPPAPORT ANDREW
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Harmon Cyrus
Olema Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Olema Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Paradigm BioCapital Advisors LP(14.3%),Paradigm BioCapital Advisors GP LLC(14.3%), etc.
Olema Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(4.49%),Bihua Chen(4.49%), etc.
Olema Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kynam Capital Management, LP(0%),Kynam Capital Management GP, LLC(0%), etc.
Olema Pharmaceuticals | 424B3: Prospectus
Olema Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(1.3%)
Olema Pharmaceuticals | EFFECT: Others
Olema Pharmaceuticals | CORRESP: CORRESP
Olema Pharmaceuticals | UPLOAD: Others
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bohen Sean
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kovacs Shane William Charles
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zojwalla Naseem
No Data